The 2024 Brain Tumor Segmentation (BraTS) Challenge: Glioma Segmentation on Post-treatment MRI
Authors:
Maria Correia de Verdier,
Rachit Saluja,
Louis Gagnon,
Dominic LaBella,
Ujjwall Baid,
Nourel Hoda Tahon,
Martha Foltyn-Dumitru,
Jikai Zhang,
Maram Alafif,
Saif Baig,
Ken Chang,
Gennaro D'Anna,
Lisa Deptula,
Diviya Gupta,
Muhammad Ammar Haider,
Ali Hussain,
Michael Iv,
Marinos Kontzialis,
Paul Manning,
Farzan Moodi,
Teresa Nunes,
Aaron Simon,
Nico Sollmann,
David Vu,
Maruf Adewole
, et al. (60 additional authors not shown)
Abstract:
Gliomas are the most common malignant primary brain tumors in adults and one of the deadliest types of cancer. There are many challenges in treatment and monitoring due to the genetic diversity and high intrinsic heterogeneity in appearance, shape, histology, and treatment response. Treatments include surgery, radiation, and systemic therapies, with magnetic resonance imaging (MRI) playing a key r…
▽ More
Gliomas are the most common malignant primary brain tumors in adults and one of the deadliest types of cancer. There are many challenges in treatment and monitoring due to the genetic diversity and high intrinsic heterogeneity in appearance, shape, histology, and treatment response. Treatments include surgery, radiation, and systemic therapies, with magnetic resonance imaging (MRI) playing a key role in treatment planning and post-treatment longitudinal assessment. The 2024 Brain Tumor Segmentation (BraTS) challenge on post-treatment glioma MRI will provide a community standard and benchmark for state-of-the-art automated segmentation models based on the largest expert-annotated post-treatment glioma MRI dataset. Challenge competitors will develop automated segmentation models to predict four distinct tumor sub-regions consisting of enhancing tissue (ET), surrounding non-enhancing T2/fluid-attenuated inversion recovery (FLAIR) hyperintensity (SNFH), non-enhancing tumor core (NETC), and resection cavity (RC). Models will be evaluated on separate validation and test datasets using standardized performance metrics utilized across the BraTS 2024 cluster of challenges, including lesion-wise Dice Similarity Coefficient and Hausdorff Distance. Models developed during this challenge will advance the field of automated MRI segmentation and contribute to their integration into clinical practice, ultimately enhancing patient care.
△ Less
Submitted 28 May, 2024;
originally announced May 2024.
The Brain Tumor Sequence Registration (BraTS-Reg) Challenge: Establishing Correspondence Between Pre-Operative and Follow-up MRI Scans of Diffuse Glioma Patients
Authors:
Bhakti Baheti,
Satrajit Chakrabarty,
Hamed Akbari,
Michel Bilello,
Benedikt Wiestler,
Julian Schwarting,
Evan Calabrese,
Jeffrey Rudie,
Syed Abidi,
Mina Mousa,
Javier Villanueva-Meyer,
Brandon K. K. Fields,
Florian Kofler,
Russell Takeshi Shinohara,
Juan Eugenio Iglesias,
Tony C. W. Mok,
Albert C. S. Chung,
Marek Wodzinski,
Artur Jurgas,
Niccolo Marini,
Manfredo Atzori,
Henning Muller,
Christoph Grobroehmer,
Hanna Siebert,
Lasse Hansen
, et al. (48 additional authors not shown)
Abstract:
Registration of longitudinal brain MRI scans containing pathologies is challenging due to dramatic changes in tissue appearance. Although there has been progress in developing general-purpose medical image registration techniques, they have not yet attained the requisite precision and reliability for this task, highlighting its inherent complexity. Here we describe the Brain Tumor Sequence Registr…
▽ More
Registration of longitudinal brain MRI scans containing pathologies is challenging due to dramatic changes in tissue appearance. Although there has been progress in developing general-purpose medical image registration techniques, they have not yet attained the requisite precision and reliability for this task, highlighting its inherent complexity. Here we describe the Brain Tumor Sequence Registration (BraTS-Reg) challenge, as the first public benchmark environment for deformable registration algorithms focusing on estimating correspondences between pre-operative and follow-up scans of the same patient diagnosed with a diffuse brain glioma. The BraTS-Reg data comprise de-identified multi-institutional multi-parametric MRI (mpMRI) scans, curated for size and resolution according to a canonical anatomical template, and divided into training, validation, and testing sets. Clinical experts annotated ground truth (GT) landmark points of anatomical locations distinct across the temporal domain. Quantitative evaluation and ranking were based on the Median Euclidean Error (MEE), Robustness, and the determinant of the Jacobian of the displacement field. The top-ranked methodologies yielded similar performance across all evaluation metrics and shared several methodological commonalities, including pre-alignment, deep neural networks, inverse consistency analysis, and test-time instance optimization per-case basis as a post-processing step. The top-ranked method attained the MEE at or below that of the inter-rater variability for approximately 60% of the evaluated landmarks, underscoring the scope for further accuracy and robustness improvements, especially relative to human experts. The aim of BraTS-Reg is to continue to serve as an active resource for research, with the data and online evaluation tools accessible at https://bratsreg.github.io/.
△ Less
Submitted 17 April, 2024; v1 submitted 13 December, 2021;
originally announced December 2021.
